Initial structure-activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles

被引:50
|
作者
Chu, L
Hutchins, JE
Weber, AE
Lo, JL
Yang, YT
Cheng, K
Smith, RG
Fisher, MH
Wyvratt, MJ
Goulet, MT
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Biochem & Physiol, Rahway, NJ 07065 USA
关键词
D O I
10.1016/S0960-894X(00)00707-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A nonpeptidyl GnRH receptor antagonist (1), with a unique 2-arylindole core, was identified through the Merck inhouse screening for binding affinity on the rat GnRH receptor. SAR studies directed toward the alkoxy-ethanolamine and 2-aryl groups resulted in a simpler lead structure with improved activity. This compound 50 exhibits a 60-fold improvement in binding activity over our initial lead 1. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:509 / 513
页数:5
相关论文
共 50 条
  • [41] DESIGN, SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES FOR IMIDAZOLYL QUINOXALINES AS AMPA RECEPTOR ANTAGONISTS
    OHMORI, J
    SHIMIZUSASAMATA, S
    OKADA, M
    SAKAMOTO, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 178 - MEDI
  • [42] A Combined Quantitative Structure-Activity Relationship Research of Quinolinone Derivatives as Androgen Receptor Antagonists
    Wang, Yuwei
    Bai, Fang
    Cao, Hong
    Li, Jiazhong
    Liu, Huanxiang
    Gramatica, Paola
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2015, 18 (09) : 834 - 845
  • [43] PHARMACOLOGICAL STUDIES ON STRUCTURE-ACTIVITY RELATIONSHIP OF MORPHINE ANTAGONISTS
    ANAND, DR
    ARZNEIMITTEL-FORSCHUNG, 1965, 15 (05): : 564 - &
  • [44] Quantitative structure-activity relationship studies on cholecystokinin antagonists
    Gupta, SP
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (02) : 111 - 124
  • [45] Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists
    Zhao, HY
    Xi, ZL
    Patel, JR
    Nelson, LTJ
    Liu, B
    Szczepankiewicz, BG
    Schaefer, VG
    Falls, HD
    Kaszubska, W
    Collins, CA
    Sham, HL
    Liu, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) : 1825 - 1828
  • [46] Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists
    Doller, D
    Chackalamannil, S
    Czarniecki, M
    McQuade, R
    Ruperto, V
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (06) : 901 - 906
  • [47] Structure-activity relationship study of diphenylamine-based estrogen receptor (ER) antagonists
    Ohta, Kiminori
    Chiba, Yuki
    Kaise, Asako
    Endo, Yasuyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (04) : 861 - 867
  • [48] Novel γ-aminobutyric acid ρ1 receptor antagonists;: Synthesis, pharmacological activity and structure-activity relationships
    Kumar, Rohan J.
    Chebib, Mary
    Hibbs, David E.
    Kim, Hye-Lim
    Johnston, Graham A. R.
    Salam, Noeris K.
    Hanrahan, Jane R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3825 - 3840
  • [49] Structure-activity relationships of novel P2-receptor antagonists structurally related to Reactive Blue 2
    Glänzel, M
    Bültmann, R
    Starke, K
    Frahm, AW
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (12) : 1262 - 1276
  • [50] Structure-activity relationships of competitive NMDA receptor antagonists
    Cheung, NS
    OCallaghan, D
    Ryan, MC
    Dutton, R
    Wong, MG
    Beart, PM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 313 (1-2) : 159 - 162